Overview
Goals and Objectives
Our Team
Lines of Research
Publications
Collaborations
Awards
Understanding the evolution of the brain and the central nervous system (CNS) has always been a key research interest as it reflects the importance of identification of mechanistic basis of crucial processes including learning, memory, perception and reactions in normal and dysfunctional conditions. This field of research has been well recognized for long time however several aspects of the connection and the communication between the neurons are yet to be identified. In addition, bridging the brain and mind and translating the neural mechanisms to neurocognitive functions represents the main pathway to draw futuristic prospects to understand the mental capacities.
Several studies have highlighted the significance of neuroscience in the educational and learning experiences which are strongly associated with neural changes in response to various learning tasks (neuroplasticity) and production of new neurons (neurogenesis). It is evident that the involvement of multiple brain regions and recruitment of substantial number of neurons to support the learning experiences are associated with higher functions such as memory and executive function.
The control of the centralized brain reaches beyond the CNS and influences various reactions via sophisticated networks including spinal cord and neuroendocrine systems. These systems establish informed bodily decisions about several stimuli including stress and manipulate the awareness and production of appropriate responses. Dysfunction of the neural systems at any level jeopardizes the critical involvement of the CNS in tuning of a wide range of vital neurophysiological, behavioral and neurocognitive processes. The global burden of the neuropsychiatric and neurological disorders has been fully appreciated by several international health organizations given the serious consequences for individuals, their families, and the healthcare systems. Specifically, neuropsychiatric disorders are the leading cause of disability in the United States, accounting for almost 19% of all years of life lost due to disability and premature death. Depression affects nearly 300 million people globally, and suicide as one of its worst outcomes, it is the second leading cause of death in 15-29-year-old individuals. Overall, nearly 800,000 people of all ages worldwide die by suicide every year. Among the population in the UAE, the prevalence of depression is reported to be 12.5–28.6% and depression has been shown to be one of the top three causes of disability-adjusted life years (DALYs) as per the Global Burden of Disease study (GBD Profile: United Arab Emirates, 2010).
Worldwide, more than 50 million people are living with dementia and every 3 seconds there is a new case of dementia and the projection for dementia and other neurological disorders is alarming. Compared to the rest of the world, few studies in the United Arab Emirates have focused on the pathogenesis and the prevalence of these disorders and this accounts for the limited advances in research and implementation of specialized care and management plans in the clinical practice.
The pathophysiological mechanisms underlying brain disorders range from disruption of molecular pathways and homeostatic neural environment to dysfunctional communication between higher-order neural networks. In this context, sustained neuroinflammation is a common hallmark shared by a large spectrum of incurable disorders including Alzheimer's, Parkinson's, multiple sclerosis, and migraine. Prevention and development of effective treatments represents a challenge due to the lack of knowledge about the processes driving the etiology, pathogenesis, and progression of these diseases.
Recognizing the necessity of advanced research in this field, we, as faculty members at the medical, pharmacy and health science colleges at University of Sharjah and University Hospital Sharjah, aim at launching a "Neurosciences and Neuropsychiatry Research Group" that will examine diverse aspects of CNS research at the basic and clinical levels.
- To identify the neural circuits of the limbic system that are involved in modulation of vital neurocognitive functions
- To investigate the role of neuroinflammation, oxidative stress, epigenetic processes in development of neuropsychiatric and neurological disorders.
- To ascertain and validate novel and potential therapeutic targets and biomarkers for the prevention and early detection of diseases and to introduce more effective care and management strategies for neuropsychiatric and neurological disorders.
- To establish successful national and international collaboration at all levels, research and academia, to tackle the devastating impact of the neurological and neuropsychiatric disorders.
- To bridge the gap between the basic and clinical research by facilitating the translation of the lab findings to improve the quality of life of individuals with neurological and neuropsychiatric disorders.
- To promote the awareness of the local community via innovative approaches to improve the perception of neuropsychiatric and neurological disorders.
- Designing strategic plans to challenge the stigma, enhance resilience and improve people's wellbeing during pandemics and other global crises.
- Pharmacology of Learning and Memory
- Neuroprotective agents
- Neurodegenerative diseases and conditions.
- Alzheimer's Disease.
- Behavioral Neuropharmacology
- Neuropsychiatric diseases: Anxiety, Depression, PTSD, Chronic Stress, etc...
- Brain Carcinoma
- Vascular Protection
- Stroke Recovery
- Brain angiogenesis
- Neuroinflammation
- Dendritic cells trafficking in the brain
- Multiple Sclerosis
- Blood-brain barrier in health and disease.
Research Publications
No Record Found
# | Entity Name | Date | Type of Collaboration |
1 | Paris-Saclay University, Gif-sur-Yvette, France. |
2021-2023 | Joint publications |
2 | St. John's University, Jamaica, Queens, NY 11439, NY, USA. | 2021-2023 | Joint publications |
3 | University of Toledo, OH, USA | 2021-2023 | Joint publications |
4 | University of Alberta, Edmonton, Canada | 2022-2023 | Joint publications |
5 | University of Heidelberg, Heidelberg, Germany | 2021-2023 | Joint publications |
6 | Université de Montréal, Montreal, Quebec, Canada | 2022-2023 | Joint publication |
7 | University of Southern California, Los Angeles, CA, USA | 2022-2023 | Joint publications |
8 | Université de Moncton, New Brunswick, Canada. | 2022-2023 | Joint publications |
9 | Queen's University Belfast, Northern Ireland, UK | 2022-2023 | Joint publications |
10 | Kingston University, London, United Kingdom | 2021-2023 | Joint publications |
11 | Universiti Sains Malaysia, Penang, Malaysia. | 2021-2023 | Joint publications |
12 | The University of Sydney, Sydney, Australia. | 2021-2023 | Joint publications |
13 | Deakin University, Victoria, Australia | 2022-2023 | Joint publications |
14 | American University of Beirut, Beirut 1107 2020, Lebanon | 2021-2023 | Joint publications |
15 | Baker Heart and Diabetes Institute, Melbourne, Australia. | 2021-2023 | Joint publications |
16 | 2021-2023 | Joint publications | |
Al-Ain University, United Arab Emirates | |||
17 | Khalifa University of Science and Technology, UAE | 2021-2023 | Joint publications |
18 | King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia | 2021-2023 | Joint publications |
19 | 2021-2023 | Joint publications | |
Jordan University of Science and Technology, Irbid, Jordan | |||
20 | Beirut Arab University, Beirut, Lebanon | 2021-2023 | Joint publications |
21 | Arabian Gulf University, Manama, Bahrain | 2021-2023 | Joint publications |
22 | University of Science and Technology, Sana'a, Yemen | 2021-2023 | Joint publications |
23 | Yarmouk University, Jordan | 2021-2023 | Joint publications |
24 | Ajman University, United Arab Emirates | 2021-2023 | Joint publications |
25 | The Hashemite University, Jordan | 2021-2023 | Joint publications |
26 | Xi'an Jiaotong, University, Xi'an, China | 2022-2023 | Joint publication |
27 | Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar. | 2021-2023 | Joint publications |
28 | The University of Jordan, Jordan | 2021-2023 | Joint publications |
29 | Al Ain University, United Arab Emirates | 2021-2023 | Joint publications |
30 | Applied Science University, Jordan | 2021-2023 | Joint publications |
31 | Qatar University, Doha, Qatar | 2021-2023 | Joint publications |
32 | Dubai Pharmacy College, United Arab Emirates | 2021-2023 | Joint publications |
33 | An-Najah National University, Nablus, Palestine | 2021-2023 | Joint publications |
34 | Fakeeh University Hospital, Dubai Silicon Oasis, Dubai, United Arab Emirates. | 2021-2023 | Joint publications |
35 | Al-Ahliyya Amman University, Amman 19328, Jordan. | 2021-2023 | Joint publications |
36 | King Saud University, Riyadh, Saudi Arabia. | 2022-2023 | Joint publications |
37 | University of Petra, Amman, Jordan. | 2021-2023 | Joint publications |
38 | Kano State Ministry of Health, Kano, Nigeria | 2021-2023 | Joint publication |
39 | Al-Zaytoonah University of Jordan, Amman, Jordan | 2021-2023 | Joint publications |
40 | New York Abu Dhabi University | 2022-2023 | Joint Project |
41 | King Abdulaziz University | 2022-2023 | Joint publications |
Prof. Karim El-zubi:
- Stanford University World's Top 2% Scientist (2019-2022).
Dr. Gulam Ashraf:
- Top 2% scientist worldwide (Stanford University/Elsevier), Since 2020.
Dr. Rania Harati
- Winner of the University of Sharjah Annual Incentive Award for Distinguished Faculty Member in Teaching, 2021.
- Winner of the Sharjah Islamic Bank Award for Distinguished Student's Research Article as supervisor, Student: Saba Hammad, awarded by Sharjah Islamic Bank, May 2022
- Second place in Poster Competition at the 6th International Conference of Pharmacy and Medicine as supervisor, Poster title “Evaluating the therapeutic potential of miR-let-7c to suppress extravasation of brain metastatic breast cancer cells", Student: Dua Hammash, awarded by The 6th International Conference of Pharmacy and Medicine, 2022
- Third place in Poster Competition at the 6th International Conference of Pharmacy and Medicine as supervisor, Poster title “miR-27a-3p regulates expression of P-glycoprotein at the brain endothelium", Student: Saba Hammad, awarded by The 6th International Conference of Pharmacy and Medicine, 2022
- Winner of the 5th best Pharmacy Student Poster Presentation Award as supervisor (Students Munazza Ahmed and Grace Daoud), Title: CRISPR-Cas9 as a potential therapeutic platform for breast cancer, Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT), Dubai, UAE, 2021.
Dr. Ahmed Alhusban:
- Chancellor's Teaching Excellence and Innovation, 2022